Crypto.com Secures MiFID Licence, Lifts Cronos (CRO) Outlook After SEC Probe Closure

Cronos (CRO), the native token of Crypto.com, has experienced positive momentum following two major regulatory milestones. Initially, the U.S. Securities and Exchange Commission (SEC) concluded its investigation into Crypto.com without any enforcement action, stabilizing legal risk and boosting market confidence. Building on this, Crypto.com further strengthened its regulatory credentials by acquiring a Markets in Financial Instruments Directive (MiFID) licence on May 21, 2025, via the purchase of A.N. Allnew Investments Ltd. This licence allows Crypto.com to offer a broader array of financial instruments—including securities, derivatives, and contracts for difference—to users in the European Economic Area (EEA). This move follows the receipt of a Markets in Crypto-Assets (MiCA) licence earlier in January 2025, reinforcing Crypto.com’s position in the regulated European crypto market. CEO Kris Marszalek underscored the firm’s commitment to delivering a compliant suite of products across the EEA. In addition, Crypto.com has launched the Canary CRO Trust for U.S. investors and made key acquisitions to support global expansion. Technical analysis indicates a bullish ascending triangle pattern in CRO, which, combined with sector optimism and positive regulatory news, could signal further price gains. In recent months, CRO reached $0.1 and previously peaked at $0.22 in December 2024. Overall, increasing institutional adoption and regulatory clarity are improving the price outlook for CRO, enhancing its appeal for both short-term trades and long-term holdings.
Bullish
Multiple regulatory achievements by Crypto.com—including the closure of the SEC investigation without enforcement and the acquisition of the MiFID licence—have reduced legal risks and expanded the platform’s offerings. This has led to renewed optimism among traders, evidenced by technical bullish signals for CRO and heightened sector sentiment. The clear regulatory path further attracts institutional interest, supporting both short-term rallies and a robust long-term outlook for CRO.